Chemed Corporation

NYSE:CHE Rapport sur les actions

Capitalisation boursière : US$8.6b

La traduction de cette page est expérimentale et en cours de développement. N'hésitez pas à vos !

Chemed Croissance future

Future contrôle des critères 1/6

Chemed is forecast to grow earnings and revenue by 13.2% and 6.8% per annum respectively while EPS is expected to grow by 13.2% per annum.

Informations clés

13.2%

Taux de croissance des bénéfices

13.2%

Taux de croissance du BPA

Healthcare croissance des bénéfices19.4%
Taux de croissance des recettes6.8%
Rendement futur des capitaux propresn/a
Couverture par les analystes

Low

Dernière mise à jour25 Jul 2024

Mises à jour récentes de la croissance future

Chemed Corporation (NYSE:CHE) Full-Year Results: Here's What Analysts Are Forecasting For This Year

Mar 01
Chemed Corporation (NYSE:CHE) Full-Year Results: Here's What Analysts Are Forecasting For This Year

Recent updates

Chemed Remains A Buy On Long-Term Economics

Aug 16

Chemed Corporation's (NYSE:CHE) Shares May Have Run Too Fast Too Soon

Jul 19
Chemed Corporation's (NYSE:CHE) Shares May Have Run Too Fast Too Soon

Chemed: Growth Does Not Justify The Current Stock Price

May 20

Here's Why Chemed Corporation's (NYSE:CHE) CEO Compensation Is The Least Of Shareholders' Concerns

May 14
Here's Why Chemed Corporation's (NYSE:CHE) CEO Compensation Is The Least Of Shareholders' Concerns

Is Chemed Corporation (NYSE:CHE) Trading At A 50% Discount?

Apr 26
Is Chemed Corporation (NYSE:CHE) Trading At A 50% Discount?

Chemed Corporation (NYSE:CHE) Full-Year Results: Here's What Analysts Are Forecasting For This Year

Mar 01
Chemed Corporation (NYSE:CHE) Full-Year Results: Here's What Analysts Are Forecasting For This Year

The Price Is Right For Chemed Corporation (NYSE:CHE)

Dec 30
The Price Is Right For Chemed Corporation (NYSE:CHE)

Chemed: Continues To Compound Shareholder Value At Double-Digit Returns

Nov 30

Chemed (NYSE:CHE) Is Aiming To Keep Up Its Impressive Returns

Oct 26
Chemed (NYSE:CHE) Is Aiming To Keep Up Its Impressive Returns

Chemed - Showcasing Why It's So Reliable

Aug 26

Chemed: Still Bullish On Economic Characteristics, But Risks Shouldn't Be Overlooked

Aug 13

Is Chemed Corporation (NYSE:CHE) Worth US$521 Based On Its Intrinsic Value?

Aug 01
Is Chemed Corporation (NYSE:CHE) Worth US$521 Based On Its Intrinsic Value?

Capital Investments At Chemed (NYSE:CHE) Point To A Promising Future

Jul 14
Capital Investments At Chemed (NYSE:CHE) Point To A Promising Future

Chemed (NYSE:CHE) Has A Rock Solid Balance Sheet

Jun 07
Chemed (NYSE:CHE) Has A Rock Solid Balance Sheet

Chemed (NYSE:CHE) Is Aiming To Keep Up Its Impressive Returns

Apr 09
Chemed (NYSE:CHE) Is Aiming To Keep Up Its Impressive Returns

Chemed Q4 2022 Earnings Preview

Feb 22

Chemed Corporation: Long-Term Tailwinds, But Remains A Hold

Feb 14

Is Chemed (NYSE:CHE) Using Too Much Debt?

Jan 05
Is Chemed (NYSE:CHE) Using Too Much Debt?

Here's What Chemed's (NYSE:CHE) Strong Returns On Capital Mean

Dec 17
Here's What Chemed's (NYSE:CHE) Strong Returns On Capital Mean

Chemed declares $0.38 dividend

Nov 04

Chemed Q3 2022 Earnings Preview

Oct 28

Does Chemed (NYSE:CHE) Have A Healthy Balance Sheet?

Oct 01
Does Chemed (NYSE:CHE) Have A Healthy Balance Sheet?

Capital Investment Trends At Chemed (NYSE:CHE) Look Strong

Sep 16
Capital Investment Trends At Chemed (NYSE:CHE) Look Strong

Buy Chemed To Reduce Equity Beta And Stabilize Portfolio Returns

Aug 26

A Look At The Intrinsic Value Of Chemed Corporation (NYSE:CHE)

Aug 16
A Look At The Intrinsic Value Of Chemed Corporation (NYSE:CHE)

Chemed declares $0.38 dividend

Aug 05

Chemed Q2 results mixed, co increases top end of FY 2022 adj. EPS guidance range

Jul 27

Prévisions de croissance des bénéfices et des revenus

NYSE:CHE - Estimations futures des analystes et données financières antérieures (USD Millions )
DateRecettesLes revenusFlux de trésorerie disponibleCash from OpMoy. Nombre d'analystes
12/31/20262,757N/AN/AN/A1
12/31/20252,630365N/AN/A2
12/31/20242,442318N/AN/A2
6/30/20242,336301253300N/A
3/31/20242,293283302354N/A
12/31/20232,264273273330N/A
9/30/20232,225245259322N/A
6/30/20232,187226280345N/A
3/31/20232,165240208269N/A
12/31/20222,135250253310N/A
9/30/20222,129262220273N/A
6/30/20222,141277284334N/A
3/31/20222,142267249303N/A
12/31/20212,139269250309N/A
9/30/20212,132308271332N/A
6/30/20212,121303283344N/A
3/31/20212,091329450507N/A
12/31/20202,080319430489N/A
9/30/20202,069271410466N/A
6/30/20202,021263413470N/A
3/31/20201,992231258317N/A
12/31/20191,939220248301N/A
9/30/20191,874209238294N/A
6/30/20191,837201218275N/A
3/31/20191,806205241296N/A
12/31/20181,783206234287N/A
9/30/20181,753206152202N/A
6/30/20181,727190123183N/A
3/31/20181,700113N/A159N/A
12/31/20171,66798N/A162N/A
9/30/20171,64276N/A198N/A
6/30/20171,61767N/A162N/A
3/31/20171,592114N/A197N/A
12/31/20161,577109N/A135N/A
9/30/20161,572106N/A187N/A
6/30/20161,566108N/A175N/A
3/31/20161,557111N/A166N/A
12/31/20151,543110N/A172N/A
9/30/20151,524110N/A172N/A
6/30/20151,496106N/A135N/A
3/31/20151,475103N/A134N/A
12/31/20141,45699N/A110N/A
9/30/20141,42592N/A66N/A
6/30/20141,40885N/A111N/A
3/31/20141,40576N/A131N/A
12/31/20131,41377N/A151N/A
9/30/20131,43381N/A190N/A

Prévisions de croissance des analystes

Taux de revenus par rapport au taux d'épargne: CHE's forecast earnings growth (13.2% per year) is above the savings rate (2.5%).

Bénéfices vs marché: CHE's earnings (13.2% per year) are forecast to grow slower than the US market (15.1% per year).

Croissance élevée des bénéfices: CHE's earnings are forecast to grow, but not significantly.

Chiffre d'affaires vs marché: CHE's revenue (6.8% per year) is forecast to grow slower than the US market (8.8% per year).

Croissance élevée des revenus: CHE's revenue (6.8% per year) is forecast to grow slower than 20% per year.

Prévisions de croissance du bénéfice par action

Rendement futur des capitaux propres

ROE futur: Insufficient data to determine if CHE's Return on Equity is forecast to be high in 3 years time

Découvrir les entreprises en croissance

7D

1Y

7D

1Y

7D

1Y